增长分化因子-15可能是胰腺癌的新生物标志物:一篇综述
1Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Medicine
|February 9, 2024
概括
增长差异化因子-15 (GDF-15) 显示为胰腺癌的新型生物标志物具有前途,有可能比CA199.9等现有标志物更改诊断和预后. 这篇评论探讨了GDF-15的情况.
科学领域:
- 瘤学和胃肠道学
- 生物标志物发现发现
背景情况:
- 胰腺癌是侵略性的,经常被发现迟,结果不好.
- 目前的生物标志物碳水化合物抗原199 (CA199) 对胰腺癌诊断有重大限制.
- 需要更好的诊断和预后工具是非常重要的.
研究的目的:
- 系统地审查生长差异化因子-15 (GDF-15) 作为胰腺癌潜在生物标志物的特征和临床效用.
- 评估GDF-15 (也称为巨抑制细胞因子-1,MIC-1) 在胰腺癌患者的诊断,疗效预测和预后中的作用.
- 提供GDF-15的作用机制和临床价值的见解,以帮助胰腺癌检测和治疗策略.
主要方法:
- 在PubMed和Web of Science数据库中进行了全面的文献搜索.
- 使用的关键词包括GDF-15,MIC-1,CA199,胰腺癌和瘤标志物.
- 对获取的研究论文进行分析和系统描述,重点关注GDF-15的特征,机制和临床相关性.
主要成果:
- GDF-15被确定为胰腺癌的一个有前途的新生物标志物.
- 与CA199.9相比,GDF-15显示了提高诊断准确性的潜力.
- 有证据表明,GDF-15在预测治疗疗效和评估患者预后方面具有实用性.
结论:
- 对于胰腺癌来说,GDF-15是CA199的一个有希望的替代品或辅助剂.
- 进一步研究GDF-15的作用可以提高早期检测和治疗策略.
- 本综述提供了关于GDF-15用于胰腺癌检测和治疗的见解.
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...